U.S. Constellation Energy, Eli Lilly, Talen Energy
Sept 13 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Constellation Energy, Eli Lilly and Talen Energy, on Friday.
HIGHLIGHTS
* Constellation Energy Corp CEG.O: Jefferies initiates with hold rating; target $183 |
* Eli Lilly LLY.N: JP Morgan raises target price to $1,100 from $1,050 |
* Moderna MRNA.O: JP Morgan cuts to underweight from neutral |
* Voya Financial Inc VOYA.N: Raymond James cuts to market perform from strong buy |
* Talen Energy Corp TLN.O: Jefferies initiates coverage with buy rating; PT $232 |
Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical order.
* Adobe Inc ADBE.O: Bernstein cuts target price to $644 from $660 |
* Adobe Inc ADBE.O: Citigroup cuts target price to $616 from $621 |
* Adobe Inc ADBE.O: UBS cuts target price to $550 from $560 |
* Advance Auto Parts, Inc. AAP.N: Wells Fargo cuts target price to $40 from $50 |
* Airbnb Inc ABNB.O: Mizuho cuts target price to $170 from $175 |
* Alaska Air Group Inc ALK.N: TD Cowen raises target price to $52 from $51 |
* Alexandria Real Estate Equities Inc ARE.N: Citigroup cuts target price to $125 from $130 |
* Alexandria Real Estate Equities Inc ARE.N: Citigroup cuts to neutral from buy |
* Allbirds Inc BIRD.O: Morgan Stanley cuts target price to $13 from $20 |
* Ally Financial Inc ALLY.N: Jefferies cuts target price to $35 from $45 |
* American Tower Corp AMT.N: BMO raises target price to $260 from $246 |
* Apellis Pharmaceuticals Inc APLS.O: JP Morgan cuts target price to $57 from $64 |
* Apellis Pharmaceuticals Inc APLS.O: Mizuho cuts target price to $39 from $42 |
* Apple Hospitality Reit, Inc. APLE.N: Wells Fargo cuts target price to $15 from $16 |
* Applovin Corp APP.O: BTIG raises target price to $150 from $114 |
* Artivion Inc AORT.N: Stifel raises target price to $30 from $28 |
* Avantor Inc AVTR.N: RBC raises target price to $34 from $31 |
* Aviat Networks Inc AVNW.O: Northland Capital cuts target price to $40 |
* Bio Rad Laboratories Inc BIO.N: RBC raises target price to $446 from $401 |
* Bio-Techne Corp TECH.O: RBC raises target price to $77 from $70 |
* Brandywine Realty Trust BDN.N: JP Morgan raises target price to $6 from $5 |
* Caleres Inc CAL.N: Telsey Advisory Group cuts target price to $37 from $43 |
* Campbell Soup Co CPB.O: RBC raises target price to $51 from $47 |
* Centene Corporation CNC.N: Wells Fargo cuts target price to $91 from $93 |
* Cintas Corp CTAS.O: Barclays cuts target price to $210 from $850 |
* Cintas Corp CTAS.O: Deutsche Bank cuts target price to $202 from $780 |
* Cognizant CTSH.O: BMO raises target price to $88 from $85 |
* Constellation Energy Corp CEG.O: Jefferies initiates with hold rating; PT $183 |
* CubeSmart CUBE.N: UBS cuts to neutral from buy |
* CubeSmart CUBE.N: UBS raises target price to $54 from $53 |
* Danaher Corp DHR.N: RBC raises target price to $333 from $300 |
* Darden Restaurants Inc DRI.N: Stephens cuts target price to $159 from $165 |
* Darling Ingredients Inc DAR.N: TD Cowen cuts target price to $43 from $45 |
* Dave & Buster's Entertainment PLAY.O: Piper Sandler cuts target price to $43 from $57 |
* Diamondrock Hospitality Company DRH.N: Wells Fargo cuts target price to $9 from $9.5 |
* Dow Inc DOW.N: Deutsche Bank cuts target price to $53 from $57 |
* Dow Inc DOW.N: JP Morgan cuts target price to $55 from $60 |
* Dow Inc DOW.N: RBC cuts target price to $55 from $57 |
* Dun & Bradstreet DNB.N: Barclays raises target price to $12 from $11 |
* Echostar Corp SATS.O: Morgan Stanley raises target price to $20 from $14 |
* Edwards Lifesciences Corp EW.N: Truist Securities cuts target price to $71 from $82 |
* Eli Lilly LLY.N: Citigroup resumes coverage with buy rating; target price $1,060 |
* Eli Lilly LLY.N: JP Morgan raises target price to $1,100 from $1,050 |
* Equifax Inc EFX.N: Barclays raises target price to $380 from $300 |
* Evolus Inc EOLS.O: Barclays raises target price to $20 from $16 |
* Evolus Inc EOLS.O: Mizuho raises target price to $25 from $23 |
* Fair Isaac Corp FICO.N: Barclays raises target price to $2150 from $1800 |
* Federal Realty Investment Trust FRT.N: Citigroup raises target price to $135 from $120 |
* Federal Realty Investment Trust FRT.N: Citigroup raises to buy from neutral |
* Ferguson Enterprises Inc FERG.N: Jefferies cuts target price to $235 from $250 |
* Flutter Entertainment Plc FLUT.N: HSBC raises target price to $209 from $198 |
* Fortinet Inc FTNT.O: Citigroup raises target price to $76 from $66 |
* Fulcrum Therapeutics Inc FULC.O: H.C. Wainwright cuts target price to $4 from $17 |
* Fulcrum Therapeutics Inc FULC.O: H.C. Wainwright cuts to neutral from buy |
* Fulcrum Therapeutics Inc FULC.O: Leerink Partners cuts target price to $4 from $16 |
* Fulcrum Therapeutics Inc FULC.O: Leerink Partners cuts to market perform from outperform |
* Fulcrum Therapeutics Inc FULC.O: RBC cuts target price to $4 from $15 |
* Fulcrum Therapeutics Inc FULC.O: RBC cuts to sector perform from outperform |
* GE Vernova Inc GEV.N: BMO initiates coverage with outperform rating; target price $245 |
* GE Vernova Inc GEV.N: Evercore ISI raises target price to $240 from $202 |
* GE Vernova Inc GEV.N: JP Morgan raises target price to $240 from $216 |
* GE Vernova Inc GEV.N: Morgan Stanley raises target price to $256 from $220 |
* General Mills Inc GIS.N: Wells Fargo raises target price to $75 from $67 |
* Halliburton Co HAL.N: RBC cuts target price to $37 from $44 |
* Halliburton Co HAL.N: RBC cuts to sector perform from outperform |
* Helmerich and Payne Inc HP.N: Citigroup cuts target price to $33 from $41 |
* Hologic Inc HOLX.O: RBC raises target price to $86 from $82 |
* Host Hotels & Resorts Inc HST.O: Wells Fargo cuts target price to $19 from $21 |
* Ibex Ltd IBEX.O: RBC raises target price to $20 from $18 |
* IBM IBM.N: BMO raises target price to $235 from $210 |
* Illumina Inc ILMN.O: RBC raises target price to $252 from $242 |
* Jefferies Financial Group Inc. JEF.N: Oppenheimer raises PT to $66 from $64 |
* Johnson & Johnson JNJ.N: HSBC raises target price to $180 from $174 |
* Kinder Morgan Inc KMI.N: Barclays raises target price to $22 from $21 |
* Kroger Co KR.N: Evercore ISI raises target price to $63 from $62 |
* Kroger Co KR.N: Jefferies raises target price to $54 from $53 |
* Kroger Co KR.N: JP Morgan raises target price to $59 from $58 |
* Kroger Co KR.N: Morgan Stanley raises target price to $58 from $57 |
* Labcorp LH.N: HSBC raises target price to $240 from $210 |
* Lyft Inc LYFT.O: Moffettnathanson raises target price to $11 from $9 |
* Manitex International Inc MNTX.O: Northland Capital cuts target price to $5.80 |
* Manitex International Inc MNTX.O: Northland Capital cuts to market perform |
* Maravai Lifesciences Holdings Inc MRVI.O: RBC raises target price to $17 from $15 |
* Marriott Vacations Worldwide VAC.N: Stifel cuts target price to $96.5 from $108 |
* Mastercard MA.N: BMO raises target price to $550 |
* McDonald's MCD.N: Citigroup raises target price to $301 from $275 |
* McKesson Corp MCK.N: Deutsche Bank cuts target price to $623 from $631 |
* Medical Properties Trust Inc MPW.N: Truist Securities raises PT to $6 from $5 |
* Moderna MRNA.O: Jefferies cuts target price to $65 from $120 |
* Moderna MRNA.O: Jefferies cuts to hold from buy |
* Moderna MRNA.O: JP Morgan cuts target price to $70 from $88 |
* Moderna MRNA.O: JP Morgan cuts to underweight from neutral |
* Moderna MRNA.O: Leerink Partners cuts target price to $46.00 from $58.00 |
* Moderna MRNA.O: Oppenheimer cuts to perform from outperform |
* Moderna MRNA.O: Oppenheimer cuts to perform rating |
* Moderna MRNA.O: Piper Sandler cuts target price to $115 from $157 |
* Moderna MRNA.O: RBC cuts target price to $75 from $90 |
* Moderna MRNA.O: TD Cowen cuts target price to $60 from $70 |
* Modivcare Inc MODV.O: Jefferies cuts target price to $14 from $25 |
* Moody's Corp MCO.N: Barclays raises target price to $570 from $500 |
* MSCI Inc MSCI.N: Barclays raises target price to $700 from $650 |
* Nature'S Sunshine Products NATR.O: Canaccord Genuity initiates coverage with buy rating |
* Nature'S Sunshine Products NATR.O: Canaccord Genuity initiates coverage with PT $18 |
* Net Power Inc NPWR.N: Capital One Securities cuts target price to $16 from $18 |
* New Fortress Energy Inc NFE.O: BTIG cuts target price to $15 from $35 |
* Noble Corporation Plc NE.N: Citigroup cuts target price to $45 from $63 |
* NRG Energy Inc NRG.N: Jefferies initiates coverage with hold rating; price target $78 |
* Omniab Inc OABI.O: RBC raises target price to $8 from $7 |
* Oracle Corp ORCL.N: Barclays raises target price to $202 from $172 |
* Oracle Corp ORCL.N: Bernstein raises target price to $201 from $175 |
* Oracle Corp ORCL.N: BofA Global Research raises price objective to $195 from $175 |
* Oracle Corp ORCL.N: Deutsche Bank raises target price to $200 from $180 |
* Oracle Corp ORCL.N: Evercore ISI raises target price to $190 from $175 |
* Oracle Corp ORCL.N: Guggenheim raises target price to $200 from $185 |
* Oracle Corp ORCL.N: JP Morgan raises target price to $140 from $120 |
* Oracle Corp ORCL.N: Piper Sandler raises target price to $185 from $175 |
* Oracle Corp ORCL.N: TD Cowen raises target price to $190 from $180 |
* Oracle Corp ORCL.N: UBS raises target price to $200 from $175 |
* Orthopediatrics Corp KIDS.O: Truist Securities raises target price to $34 from $30 |
* Oruka Therapeutics Inc ORKA.O: Jefferies initiates coverage with buy rating; PT $40 |
* Oxford Industries Inc OXM.N: Citigroup cuts target price to $65 from $92 |
* Park Hotels & Resorts Inc PK.N: Wells Fargo cuts target price to $14.5 from $17 |
* Patterson-UTI Energy Inc PTEN.O: Citigroup cuts target price to $11 from $12.5 |
* Pebblebrook Hotel Trust PEB.N: Wells Fargo cuts target price to $13 from $15 |
* Public Service Enterprise Group PEG.N: Jefferies initiates with hold rating; PT $85 |
* Quidelortho Corp QDEL.O: RBC raises target price to $62 from $61 |
* Radiant Logistics Inc RLGT.A: TD Cowen cuts target price to $8.50 from $9.50 |
* Repligen Corp RGEN.O: RBC raises target price to $205 from $190 |
* RH RH.N: BofA Global Research raises price objective to $359 from $310 |
* RH RH.N: Citigroup raises target price to $355 from $340 |
* RH RH.N: Jefferies raises target price to $294 from $272 |
* RH RH.N: Morgan Stanley raises target price to $310 from $300 |
* RH RH.N: TD Cowen raises target price to $350 from $325 |
* RH RH.N: Wedbush raises target price to $310 from $250 |
* RH RH.N: Wells Fargo raises target price to $350 from $325 |
* RLJ Lodging Trust RLJ.N: Wells Fargo cuts target price to $9 from $11 |
* RLJ Lodging Trust RLJ.N: Wells Fargo cuts to underweight from equal weight |
* Ryman Hospitality Properties Inc RHP.N: Wells Fargo cuts target price to $115 from $127 |
* S&P Global Inc. SPGI.N: Barclays raises target price to $610 from $550 |
* Sabra Health Care REIT Inc SBRA.O: Citigroup raises target price to $20 from $17 |
* Sabra Health Care REIT Inc SBRA.O: Citigroup raises to buy from neutral |
* Seadrill Ltd (Hamilton) SDRL.N: Citigroup cuts target price to $52 from $60 |
* Seadrill Ltd (Hamilton) SDRL.N: Citigroup raises to buy from neutral |
* Service Properties Trust SVC.O: Wells Fargo cuts target price to $4 from $5 |
* Shoals Technologies Group Inc SHLS.O: Jefferies raises target price to $6 from $5 |
* SL Green Realty Corp SLG.N: Citigroup raises target price to $66 from $44 |
* SL Green Realty Corp SLG.N: Citigroup raises to neutral from sell |
* Sunstone Hotel Investors Inc SHO.N: Wells Fargo raises to equal weight from underweight |
* Talen Energy Corp TLN.O: Jefferies initiates coverage with buy rating; PT $232 |
* Tesla Inc TSLA.O: Guggenheim raises target price to $153 from $134 |
* Thermo Fisher Scientific Inc TMO.N: Leerink Partners raises target price to $645 from $600 |
* Thermo Fisher Scientific Inc TMO.N: RBC raises target price to $767 from $664 |
* TKO Group TKO.N: Pivotal Research initiates coverage with buy rating; target price $170 |
* Trade Desk Inc TTD.O: Wedbush raises target price to $115 from $110 |
* TransUnion TRU.N: Barclays raises target price to $105 from $80 |
* Travere Therapeutics Inc TVTX.O: JP Morgan raises target price to $23 from $20 |
* Unity Software Inc U.N: Jefferies raises target price to $20 from $16 |
* Unity Software Inc U.N: Jefferies raises target price to $20 from $16 |
* Unity Software Inc U.N: Stifel raises target price to $25 from $20 |
* US Bancorp USB.N: KBW raises target price to $49 from $46 |
* Ventas Inc VTR.N: Raymond James raises target price to $68 from $65 |
* Verisk Analytics VRSK.O: Barclays raises target price to $310 from $275 |
* Viridian Therapeutics Inc VRDN.O: RBC raises target price to $44 from $35 |
* Viridian Therapeutics Inc VRDN.O: Wedbush raises target price to $45 from $42 |
* Vistra Corp VST.N: Jefferies initiates coverage with buy rating; price target $99 |
* Voya Financial Inc VOYA.N: Raymond James cuts to market perform from strong buy |
* Western Digital Corp WDC.O: TD Cowen cuts target price to $80 from $95 |
* World Kinect Corporation WKC.N: BofA Global Research raises price objective to $27 from $24 |
* Wynn Resorts Ltd WYNN.O: Stifel cuts target price to $103 from $121 |
* Xenia Hotels & Resorts, Inc. XHR.N: Wells Fargo cuts target price to $15 from $16 |
* Xenia Hotels & Resorts, Inc. XHR.N: Wells Fargo raises to overweight from equal weight |
* Zimmer Biomet Holdings Inc ZBH.N: Truist Securities cuts target to $112 from $117 |
(Compiled by Bengaluru Newsroom)
</body></html>Relaterade tillgångar
Senaste nytt
Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.
Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.
Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.
